Expression of insulin-like growth factors in remyelination following ethidium bromide-induced demyelination in the mouse spinal cord

Neuropathology

Volumn 24, Issue 3, 2004, Pages 208-218

  Fushimi, Shigeko ^a   Shirabe, Teruo ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Insulin like growth factor I; Insulin like growth factor I receptor; Insulin like growth factor II; Insulin like growth factor II receptor; Remyelination

Indexed keywords

ETHIDIUM BROMIDE; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; DEMYELINATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REMYELINIZATION; SCHWANN CELL; SPINAL CORD; TISSUE LEVEL;

ANIMALS; DEMYELINATING DISEASES; ETHIDIUM; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED BALB C; MYELIN SHEATH; RNA, MESSENGER; SOMATOMEDINS;

EID: 3843106167     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2004.00561.x     Document Type: Article

References (52)

1. Wilczak N, De Keyser J. Insulin-like growth factor-I receptors in normal appearing white matter and chronic plaques in multiple sclerosis. Brain Res 1997; 772: 243-246.
2. Gveric D, Cuzner ML, Newcombe J. Insulin-like growth factors and binding proteins in multiple sclerosis plaques. Neuropahtol Appl Neurobiol 1999; 25: 215-225.
3. Barres BA, Hart IK, Coles HS et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31-46.
4. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993; 118: 283-295.
5. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 2000; 20: 5703-5708.
6. McMorris FA, Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res 1988; 21: 199-209.
7. Masuda S, Chikuma M, Sasaki R. Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes. Brain Res 1997; 746: 63-70.
8. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 1996; 13: 227-255.
9. Beck H, Samani NJ, Byrne S, Morgan K, Gebhard R, Brammar WJ. Histochemical localization of IGF-I and IGF-II mRNA in the rat between birth and adulthood. Development 1988; 104: 29-39.
10. Stylianopoulou F, Herbert J, Soares MB, Efstratiadis A. Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci USA 1988; 85: 141-145.
11. Hynes MA, Brooks PJ, Van Wyk JJ, Lund PK. Insulin-like growth factor II messenger ribonucleic acids are synthesized in the choroid plexus of the rat brain. Mol Endocrinol 1988; 2: 47-54.
12. Lim R, Miller JF, Hicklin DJ, Holm AC, Ginsberg BH. Mitogenic activity of glia maturation factor. Interaction with insulin and insulin-like growth factor-II. Exp Cell Res 1985; 159: 335-343.
13. Mill JF, Chao MV, Ishii DN. Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation. Proc Natl Acad Sci USA 1985; 82: 7126-7130.
14. DiCicco-Bloom E, Black IB. Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts. Proc Natl Acad Sci USA 1988; 85: 4066-4070.
15. Cheng B, Mattson MP. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci 1992; 12: 1558-1566.
16. Konishi Y, Takahashi K, Chi DH, Rosenfeld RG. Insulin-like growth factor II promotes in vitro cholinergic development of mouse septal neurons: comparison with the effects of insulin-like growth factor I. Brain Res 1994; 649: 53-61.
17. Fushimi S, Morisada Y, Shirabe T. Experimental Demyelination and remyeination induced by ethidium bromide (in Japanese with English abstract). Kawasaki Igakkai Shi 1992; 18: 227-236.
18. Fushimi S, Higashi Y, Morisada Y, Shirabe T. Microglial reactions to demyelinating lesions induced by ethidium bromide (in Japanese with English abstract). Kawasaki Igakkai Shi 1993; 19: 169-179.
19. Fushimi S, Shirabe T. The reaction of glial progenitor cells in remyelination following ethidium bromide-induced demyelination in the mouse spinal cord. Neuropathology 2002; 22: 233-242.
20. D'Ercole AJ, Ye P, O'Kusky JR. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 2002; 36: 209-220.
21. Dore S, Kar S, Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997; 20: 326-231.
22. Lai EC, Felice KJ, Festoff BW et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology 1997; 49: 1621-1630.
23. Hinks GL, Flanklin RJM. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Moll Cell Neurosci 1999; 14: 153-168.
24. O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ, Wood TL. IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 2002; 39: 85-97.
25. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988; 241: 708-712.
26. Arkins S, Rebeiz N, Biragyn A, Reese DL, Kelly KW. Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 1993; 133: 2334-2343.
27. Lee WH, Clemens JA, Bondy CA. Insulin-like growth factors in the response to cerebral ischemia. Mol Cell Neurosci 1992; 3: 36-43.
28. Garcia-Estrada J, Garcia-segura LM, Torres-Aleman I. Expression of insulin-like growth factor I by astrocytes in response to injury. Brain Res 1992; 592: 343-347.
29. Yao DL, West NR, Bondy CA et al. Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration. J Neurosci Res 1995; 40: 647-659.
30. Komoly S, Hudson LD, Webster HD, Bondy CA. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 1992; 89: 1894-1898.
31. Liu X, Yao DL, Bondy CA et al. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 1994; 5: 418-430.
32. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin-1β promotes repair of the CNS. J Neurosci 2001; 21: 7046-7052.
33. Diemel LT, Copelman CA, Cuzner ML. Macrophages in CNS remyelination: friend or foe? Neurochem Res 1998; 23: 341-347.
34. Kotter MR, Setzu A, Sim FJ, van Rooijen N, Franklin RJM. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001; 35: 204-212.
35. Carson MJ, Behringer RR, Rinster RL, Mamorriss FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993; 10: 729-740.
36. Ye P, Carson J, D'Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 1995; 15: 7344-7356.
37. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82.
38. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 receptor (IGF1R). Cell 1993; 75: 59-72.
39. Powell-Braxton L, Hollingshead P, Warburton C et al. IGF-I is required for normal embryonic growth in mice. Genes Dev 1993; 7: 2609-2617.
40. McMorris FA, Furlanetto RW, Mozell RL, Carson MJ, Raible DW. Regulation of oligodendrocyte development by insulin-like growth factors and cyclic nucleotides. Ann NY Acad Sci 1990; 605: 101-109.
41. Haselbacher G, Humbel R. Evidence for two species of insulin-like growth factor II (IGF II and 'big' IGF II) in human spinal fluid. Endocrinology 1982; 110: 1822-1824.
42. Haselbacher GK, Schwab ME, Pasi A, Humbel RE. Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms. Proc Natl Acad Sci USA 1985; 82: 2153-2157.
43. Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 2002; 22: 6041-6051.
44. Walter HJ, Berry M, Hill DJ, Cwyfan-Hughes S, Holly JMP, Logan A. Distinct sites of insulin-like growth factor (IGF)-II expression and localization in lesioned rat brain: possible roles of IGF-binding proteins (IGFPs) in the mediation of IGF-II activity. Endocrinology 1999; 140: 520-532.
45. Cheng HL, Radolph A, Yee D, Delafontine P, Tennekoon G, Feldman EL. Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J Neurochem 1996; 66: 525-536.
46. 0 expression and DNA synthesis by insulin-like growth factors in vitro. Eur J Neurosci 1996; 8: 553-564.
47. Meier C, Parmantier E, Brennan A, Mirsky R, Jessen KR. Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci 1999; 19: 3847-3859.
48. Bandtlow CE, Heumann R, Schwab ME, Thoenen H. Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J 1987; 6: 891-899.
49. Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002; 22: 3052-3060.
50. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 1994; 367: 371-375.
51. Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA. Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 1996; 16: 6433-6442.
52. Jean I, Lavialle C, Barthelaix-Pouplard A, Fressinaud C. Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS. Brain Res 2003; 972: 110-118.